High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions

Journal of Surgical Oncology

Volumn 98, Issue 6, 2008, Pages 415-420

  Bacci, Gaetano ^a,d   Rocca, Michele ^b   Salone, Mariacristina ^b   Balladelli, Alba ^c   Ferrari, Stefano ^a   Palmerini, Emanuela ^a   Forni, Cristiana ^a   Briccoli, Antonio ^b  

^a Chemotherapy   (Italy)

^b NONE   (Italy)

^c Laboratory of Oncologic Research   (Italy)

^d Sezione di Chemioterapia   (Italy)

Author keywords

Bone sarcoma; Pulmonary metastases; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; IFOSFAMIDE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN TISSUE; LIMB SALVAGE; LIMB TUMOR; LUNG METASTASIS; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; THORACOTOMY; THROMBOCYTOPATHY; TREATMENT DURATION;

ADOLESCENT; ADULT; AMPUTATION; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; DIAGNOSTIC IMAGING; DISEASE-FREE SURVIVAL; EXTREMITIES; FEMALE; HUMANS; LIMB SALVAGE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OSTEOSARCOMA; PNEUMONECTOMY; RETROSPECTIVE STUDIES;

EID: 55749100652     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21140     Document Type: Article

References (19)

1. Longhi A, Errani C, De Paolis M, et al.: Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev 2006;32: 423-436.
2. Marina NM, Pratt CB, Rao BN, et al.: Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer 1992;70:2722-2727. Erratum in: Cancer 1993; 71:2879.
3. Meyers PA, Heller G, Healey JH, et al.: Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993;11:449-453.
4. Pacquement H, Kalifa C, Fagnou C, et al.: Metastatic osteogenic sarcoma at diagnosis. Study of 73 cases from the French Society of Pediatric Oncology (SFOP) between 1980 and 1990. Acta Orthop Scand 1997;68:(Suppl 276):S124.
5. Harris MB, Gieser P, Goorin AM, et al.: Treatment of metastatic osteosarcoma at diagnosis: A Pediatric Oncology Group Study. J Clin Oncol 1998;16:3641-3648.
6. Kaste SC, Pratt CB, Cain AM, et al.: Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: Imaging features. Cancer 1999;86:1602-1608.
7. Ferguson WS, Harris MB, Goorin AM, et al.: Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol 2001;23: 340-348.
8. Goorin AM, Harris MB, Bernstein M, et al.: Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A pediatric oncology group trial. J Clin Oncol 2002; 20:426-433.
9. Kager L, Zoubek A, Pötschger U, et al.: Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003;21:2011-2018.
10. Mialou V, Philip T, Kalifa C, et al.: Metastatic osteosarcoma at diagnosis: Prognostic factors and long-term outcome - The French pediatric experience. Cancer 2005;104:1100-1109.
11. Thompson RC, Jr., Cheng EY, Clohisy DR, et al.: Results of treatment for metastatic osteosarcoma with neoadjuvant chemotherapy and surgery. Clin Orthop Relat Res 2002;397:240-247.
12. Daw NC, Billups CA, Rodriguez-Galindo C, et al.: Metastatic osteosarcoma. Cancer 2006;106:403-412.
13. Bcci G, Mercuri M, Briccoli A, et al.: Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer 1997; 79:245-254.
14. Bacci G, Briccoli A, Ferrari S, et al.: Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: Treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide. Oncol Rep 2000;7:339-346.
15. Bacci G, Longhi A, Versari M, et al.: Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006;106:1154-1161.
16. Ferrari S, Smeland S, Mercuri M, et al.: Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005;23:8845-8852.
17. Picci P, Bacci G, Campanacci M, et al.: Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer 1985;56:1515-1521.
18. Eccles SA, Welch DR: Metastasis: Recent discoveries and novel treatment strategies. Lancet 2007;369:1742-1757. Review.
19. Nachman J, Simon MA, Dean L, et al.: Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. J Clin Oncol 1987;5:1185-1190.